New shot formula may hurt less: study tests patient comfort
NCT ID NCT05913817
First seen Mar 28, 2026 · Last updated Apr 28, 2026 · Updated 5 times
Summary
This study involved 324 adults with conditions like Crohn's disease, arthritis, or psoriasis who were already using a standard adalimumab injection. They switched to a higher-concentration version (AVT-02) to see if it caused less pain at the injection site and if patients stuck with the treatment. Researchers measured pain levels and patient satisfaction over 180 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
JAMP Pharma Corporation
Montreal, Quebec, J4B 5H3, Canada
Conditions
Explore the condition pages connected to this study.